Health Care
America has the most advanced health care in the world, in large part due to private sector-led innovation and employer-sponsored healthcare coverage.
While Americans benefit tremendously from ongoing advancements in bioscience, technology, and care, we continue to wrestle with the challenge of making quality health care more affordable, more accessible, and more reliable for all Americans. At the U.S. Chamber, we’re pushing for value-based healthcare solutions that reduce costs and reward quality outcomes.
Take action to protect American patients
The Department of Health and Human Services (HHS) have started the process of imposing government price controls on critical medical treatments. This will have devastating consequences for patients who are counting on new life-saving drugs.
Unless we act, this is going to happen to us.
Join us in urging Congress to protect American patients and stop this price control regime!
Read these first
- How Virtual Reality Is Transforming HealthcareHealth practitioners are exploring exciting ways that VR can assist patients and health providers to achieve better treatments and outcomes.Learn More
- Growing By Investing In Health Across The AmericasBusiness and government leaders discuss the importance of investing in healthcare and citizens’ well-being for a better future for the nations of the Americas.Learn More
- Experts Weigh In on the Future of Healthcare and the WorkforceThe U.S. Chamber AI Commission hosted a field hearing in Cleveland, OH, examining how AI is impacting the healthcare industry.Learn More
Feature video
HRSA's Carole Johnson discusses rising U.S. maternal mortality rates and the national initiatives aiming to reverse this trend.
Feature story
Ninety four percent of employers report making new investments in care for mental health and substance use disorders.
Spotlight on Mental Health
Become a part of the world’s largest business organization and network
U.S. Chamber members range from small businesses and chambers of commerce across the country to startups in fast-growing sectors, leading industry associations, and global corporations.
Discover the ROI Chamber membership can deliver for you.
Our Work
The U.S. Chamber is promoting effective private sector solutions to our health care challenges. These solutions will help control costs, expand access, and improve the quality of care. We support policy that strengthens the employer-based model of coverage, through which 180 million Americans receive—and overwhelmingly like—their health care.
Related Litigation
Events
- Small BusinessCO— Small Business DayWednesday, May 0112:00 PM EDT - 02:00 PM EDTLearn More
- Security and Resilience13th Annual Building Resilience ConferenceWednesday, May 15 - Friday, May 1708:00 AM EDT - 03:00 PM EDTLearn More
- Environment and Sustainability2024 Sustainability and Circular Economy SummitTuesday, June 0408:30 AM EDT - 01:30 PM EDTLearn More
Latest Content
On Tuesday, June 6, 2017, this letter was sent to the members of the House Energy and Commerce Committee opposing any amendments that may be offered to H.R. 2430, the FDA Reauthorization Act (FDARA) of 2017, that would allow the importation of foreign pharmaceuticals into the United States or that would undermine the preemptive authority of federal food and drug regulations. The Committee will mark up the bill tomorrow morning. June 6, 2017 Dear Chairman Walden and Ranking Member Pallone:
On May 23, 2017, the U.S. Chamber of Commerce sent this letter to Senate Finance Committee Chairman Orrin Hatch that outlined several legislative reform recommendations as the Senate moves forward with crafting their own proposal for the repeal and replacement of Obamacare.
Consumers who buy their own insurance may soon be forced out of the market.
On Friday, May 19, the Chamber, along with 7 other trade associations representing insurers, hospitals, physicians and employers, sent a letter to U.S. Department of Health and Human Services Secretary Tom Price. The letter outlines serious concerns about the continued uncertainty around funding for cost-sharing reduction (CSR) payments and the negative impacts uncertainty will have on millions of Americans if it is not addressed.
On Friday, May 19, the Chamber, along with 7 additional trade associations representing insurers, hospitals, physicians and employers, sent a letter to Office of Management and Budget Director Mick Mulvaney. The letter outlines serious concerns about the continued uncertainty around funding for cost-sharing reduction (CSR) payments and the negative impacts uncertainty will have on millions of Americans if it is not addressed.
This letter was sent to the members of the House Subcommittee on Health opposing any amendments that may be offered to the Food and Drug Administration Reauthorization Act of 2017 that would allow the importation of foreign pharmaceuticals into the United States or that would undermine the preemptive authority of federal food and drug regulations. The Subcommittee is marking up the bill tomorrow morning. May 17, 2017
When Americans buy medication, the last thing they should worry about is whether they are getting what they paid for.
This letter was sent to the members of the Senate Committee on Health, Education, Labor, and Pensions opposing amendments that may be offered to S. 934, the Food and Drug Administration Reauthorization Act, that would allow the importation of foreign pharmaceuticals into the United States or that would undermine the preemptive authority of federal food and drug regulations. May 9, 2017
WASHINGTON, D.C. —U.S. Chamber of Commerce President and CEO Thomas J. Donohue issued the following statement today following House passage of the “American Health Care Act”: “We congratulate the U.S. House of Representatives for passing the ‘American Health Care Act’ and taking an important step forward from an unsustainable health care system that is saddling Americans with higher costs and uncertain coverage options.